FOREGUT NEUROENDOCRINE TUMOR

Clinical trials for FOREGUT NEUROENDOCRINE TUMOR explained in plain language.

Never miss a new study

Get alerted when new FOREGUT NEUROENDOCRINE TUMOR trials appear

Sign up with your email to follow new studies for FOREGUT NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug shows promise in slowing rare carcinoid tumors

Disease control Ongoing

This study tested a drug called pazopanib in 171 people with carcinoid tumors that were getting worse. The goal was to see if pazopanib could slow tumor growth compared to a placebo. Participants were randomly assigned to receive either the drug or a placebo, and researchers meas…

Matched conditions: FOREGUT NEUROENDOCRINE TUMOR

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 29, 2026 00:51 UTC

FOREGUT NEUROENDOCRINE TUMOR

Get alerted when new FOREGUT NEUROENDOCRINE TUMOR trials appear

New drug shows promise in slowing rare carcinoid tumors